Everest Medicines Limited (HKG:1952)
Hong Kong
· Delayed Price · Currency is HKD 58.45
+1.65 (2.90%)
Apr 3, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 18.96 billion as of April 4, 2025. Its market cap has increased by 107.43% in one year.
Market Cap
18.96B
Enterprise Value
17.87B
Revenue
752.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.45
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 18.96B, a decrease of -8.12%. That is a compound annual growth rate of -1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 18.96B | 21.62% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 221.06B |
| Hansoh Pharmaceutical Group Company | 140.64B |
| JD Health International | 105.59B |
| WuXi Biologics | 101.82B |
| Innovent Biologics | 82.32B |
| Akeso | 77.10B |
| Alibaba Health Information Technology | 76.55B |
| Sichuan Kelun-Biotech Biopharmaceutical | 70.23B |